At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 16:19 ET
James Barry, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 1,400 shares of common stock with an approximate market value of $539,877. The shares were acquired through restricted stock vestings in September 2026. The sale is small relative to the company's $9.9B market cap and represents a routine insider sale.
- James Barry, an officer of Bio-Rad Laboratories, filed a Form 144 on November 9, 2026.
- The proposed sale is for 1,400 shares of common stock.
- The approximate market value of the proposed sale is $539,877.
- The shares were acquired through restricted stock vestings on September 1, 5, and 6, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access